- Home
- AUPH vs UTI Comparison
AUPH vs UTI Comparison
Compare AUPH & UTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- UTI
- Stock Information
- Founded
- AUPH 1993
- UTI 1965
- Country
- AUPH Canada
- UTI United States
- Employees
- AUPH N/A
- UTI N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- UTI Other Consumer Services
- Sector
- AUPH Health Care
- UTI Real Estate
- Exchange
- AUPH Nasdaq
- UTI Nasdaq
- Market Cap
- AUPH 1.1B
- UTI 1.4B
- IPO Year
- AUPH 1999
- UTI 2003
- Fundamental
- Price
- AUPH $8.86
- UTI $31.25
- Analyst Decision
- AUPH Strong Buy
- UTI Strong Buy
- Analyst Count
- AUPH 2
- UTI 6
- Target Price
- AUPH $11.50
- UTI $34.83
- AVG Volume (30 Days)
- AUPH 1.9M
- UTI 664.1K
- Earning Date
- AUPH 07-31-2025
- UTI 08-05-2025
- Dividend Yield
- AUPH N/A
- UTI N/A
- EPS Growth
- AUPH N/A
- UTI 155.82
- EPS
- AUPH 0.27
- UTI 1.04
- Revenue
- AUPH $247,295,000.00
- UTI $782,692,000.00
- Revenue This Year
- AUPH $12.15
- UTI $14.34
- Revenue Next Year
- AUPH $18.31
- UTI $8.02
- P/E Ratio
- AUPH $33.04
- UTI $29.94
- Revenue Growth
- AUPH 29.20
- UTI 14.69
- 52 Week Low
- AUPH $5.20
- UTI $15.14
- 52 Week High
- AUPH $10.67
- UTI $36.32
- Technical
- Relative Strength Index (RSI)
- AUPH 64.10
- UTI 40.16
- Support Level
- AUPH $7.36
- UTI $31.02
- Resistance Level
- AUPH $9.10
- UTI $32.62
- Average True Range (ATR)
- AUPH 0.44
- UTI 1.29
- MACD
- AUPH 0.10
- UTI -0.28
- Stochastic Oscillator
- AUPH 89.53
- UTI 23.54
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About UTI Universal Technical Institute Inc
Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.